Side effects: a prosecutor, a whistleblower, and a bestselling antidepressant on trial
Chris Chaloner , Freelance healthcare ethics consultant
THIS IS a true story about the influence that drug companies exert on clinical practice and the impact this has on clinicians, researchers and patients. At the heart of what is a well-told and gripping story is a New York-based attorney who led an unprecedented lawsuit against one of the biggest pharmaceutical companies.
Mental Health Practice.
15, 10, 8-8.
doi: 10.7748/mhp.15.10.8.s4
Want to read more?
Already have access? Log in
or
3-month trial offer for £5.25/month
Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
- Unlimited access to all 10 RCNi Journals
- RCNi Learning featuring over 175 modules to easily earn CPD time
- NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
- Personalised newsletters tailored to your interests
- A customisable dashboard with over 200 topics
Subscribe
Alternatively, you can purchase access to this article for the next seven days.
Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
